Order Article Reprints

Musallam AA, Aldeeb RA, Mansour RM, Kassem MAE-k, Saeed DF, Mahdy MA, Abdelnaby RM, Elnahas HM, Ibrahim TM. Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. Pharmaceuticals. 2025; 18(7):972. https://doi.org/10.3390/ph18070972

Musallam, Abeer A., Reem A. Aldeeb, Riham M. Mansour, Manar Abd El-karim Kassem, Doaa Fayez Saeed, Mahmoud A. Mahdy, Rana M. Abdelnaby, Hanan M. Elnahas, and Tarek M. Ibrahim. 2025. "Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment" Pharmaceuticals 18, no. 7: 972. https://doi.org/10.3390/ph18070972

Musallam, A. A., Aldeeb, R. A., Mansour, R. M., Kassem, M. A. E.-k., Saeed, D. F., Mahdy, M. A., Abdelnaby, R. M., Elnahas, H. M., & Ibrahim, T. M. (2025). Development of a Novel Drug Delivery System “Nanoemulfoam” for Topical Delivery of Terbinafine Hydrochloride as a Repurposed Therapy in Skin Cancer: Formulation, Optimization, In Vitro Characterization, Ex Vivo Transdermal Permeability, Cytotoxicity Studies, and In Silico Assessment. Pharmaceuticals, 18(7), 972. https://doi.org/10.3390/ph18070972